The UK medicines and healthcare products regulatory agency (MHRA) has announced the start of consultations on new proposals in the field of school health care. The proposal concerns the possibility of giving educational institutions the right to store spare adrenaline nasal sprays on school premises. The initiative is aimed at expanding support measures for children at risk of anaphylaxis — a severe, potentially life-threatening allergic reaction. Adrenaline nasal sprays are being considered as an alternative to traditional auto-injectors (pen-type syringes), which are already permitted to be stored in some schools as backup emergency aid. If the proposal is approved, schools will gain an additional tool for rapid response in the event that a child experiences an acute allergic reaction and their personal emergency aid device is unavailable, defective, or expired. Supporters of the initiative note that the nasal administration of adrenaline may be easier for school staff to use compared to injection devices, which could potentially reduce the risk of errors in administering first aid. The MHRA consultation involves gathering opinions from medical professionals, educational institutions, parents, and other stakeholders before a final decision is made. The regulator emphasises that the goal of the initiative is to increase the safety of children with severe allergies in the school environment and provide school personnel with greater capacity for timely response to emergency situations.